Overexpression of the coactivator bridge-1 results in insulin deficiency and diabetes

Molecular Endocrinology

Volumn 20, Issue 1, 2006, Pages 167-182

  Volinic, Jamie L ^a   Lee, Jee H ^a   Eto, Kazuhiro ^a   Kaur, Varinderpal ^a   Thomas, Melissa K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIDGE 1 PROTEIN; GLUCAGON; INSULIN; PDZ PROTEIN; UNCLASSIFIED DRUG;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COMPARTMENTALIZATION; CELL COUNT; CELL SURVIVAL; CONTROLLED STUDY; CYTOARCHITECTURE; DIABETES MELLITUS; ENDOCRINE CELL; EXOCRINE CELL; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN DEFICIENCY; MALE; MORPHOGENESIS; MOUSE; NEWBORN; NONHUMAN; PANCREAS; PANCREAS DUCT; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL LINE; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, TRANSGENIC; PANCREAS; RATS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

ANIMALIA; MUS MUSCULUS;

EID: 28044433467     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0127     Document Type: Article

References (75)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
2. Gerich JE 2003 Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447-456
3. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim HS, Lee IK, Bonner-Weir S 2003 Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300-2308
4. Fajans SS, Bell GI, Polonsky KS 2001 Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971-980
5. Steiner DF, Chan SJ, Welsh JM, Kwok SC 1985 Structure and evolution of the insulin gene. Annu Rev Genet 19:463-484
6. German MS, Wang J, Chadwick RB, Rutter WJ 1992 Synergistic activation of the insulin gene by a LIM-homeodomain protein and a basic helix-loop-helix protein: building a functional insulin mini-enhancer complex. Genes Dev 6:2165-2176
7. Ohneda K, Mirmira RG, Wang J, Johnson JD, German MS 2000 The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol 20:900-911
8. Asahara H, Dutta S, Kao HY, Evans RM, Montminy M 1999 Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol Cell Biol 19:8219-8225
9. Qiu Y, Guo M, Huang S, Stein R 2002 Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol Cell Biol 22:412-420
10. Stanojevic V, Habener JF, Thomas MK 2004 Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300. Endocrinology 145:2918-2928
11. Thomas MK, Yao KM, Tenser MS, Wong GG, Habener JF 1999 Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription. Mol Cell Biol 19:8492-8404
12. Stanojevic V, Yao KM, Thomas MK 2005 The coactivator Bridge-1 increases transcriptional activation by pancreas duodenum homeobox-1 (PDX-1). Mol Cell Endocrinol 237:67-74
13. Stoffers DA, Heller RS, Miller CP, Habener JF 1999 Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional reporter. Endocrinology 140:5374-5381
14. Gannon M, Gamer LW, Wright CV 2001 Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. Dev Biol 238:185-201
15. Sander M, Sussel L, Conners J, Scheel D, Kalamaras J, Dela Cruz F, Schwitzgebel V, Hayes-Jordan A, German M 2000 Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of β-cell formation in the pancreas. Development 127:5533-5540
16. Thomas MK, Habener JF 2004 IDX-1: pancreatic agenesis and type 2 diabetes. In: Erikson P, Epstein CJ, Wynshaw-Boris A, eds. Molecular basis of inborn errors of development. Oxford, UK: Oxford University Press; 552-556
17. Sharma S, Jhala US, Johnson T, Ferreri K, Leonard J, Montminy M 1997 Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1. Mol Cell Biol 17:2598-2604
18. Wu KL, Gannon M, Peshavaria M, Offield MF, Henderson E, Ray M, Marks A, Gamer LW, Wright CV, Stein R 1997 Hepatocyte nuclear factor 3β is involved in pancreatic β-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 17:6002-6013
19. Lee CS, Sund NJ, Vatamaniuk MZ, Matschinsky FM, Stoffers DA, Kaestner KH 2002 Foxa2 controls Pdx1 gene expression in pancreatic β-cells in vivo. Diabetes 51:2546-2551
20. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs 3rd WH, Wright CV, White MF, Arden KC, Accili D 2002 The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839-847
21. Olbrot M, Rud J, Moss LG, Sharma A 2002 Identification of β-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci USA 99:6737-6742
22. Matsuoka TA, Zhao L, Artner I, Jarrett HW, Friedman D, Means A, Stein R 2003 Members of the large Maf transcription family regulate insulin gene transcription in islet β cells. Mol Cell Biol 23:6049-6062
23. Hussain MA, Lee J, Miller CP, Habener JF 1997 POU domain transcription factor brain 4 confers pancreatic α-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element. Mol Cell Biol 17:7186-7194
24. Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull J, Gradwohl G, Gruss P 2003 Opposing actions of Arx and Pax4 in endocrine pancreas development. Genes Dev 17:2591-2603
25. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H 1999 Notch signalling controls pancreatic cell differentiation. Nature 400:877-881
26. Gradwohl G, Dierich A, LeMeur M, Guillemot F 2000 Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 97:1607-1611
27. Huang HP, Liu M, El-Hodiri HM, Chu K, Jamrich M, Tsai MJ 2000 Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. Mol Cell Biol 20:3292-3307
28. German MS, Wang J 1994 The insulin gene contains multiple transcriptional elements that respond to glucose. Mol Cell Biol 14:4067-4075
29. Marshak S, Totary H, Cerasi E, Melloul D 1996 Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci USA 93:15057-15062
30. Seijffers R, Ben-David O, Cohen Y, Karasik A, Berezin M, Newgard CB, Ferber S 1999 Increase in PDX-1 levels suppresses insulin gene expression in RIN 1046-38 cells. Endocrinology 140:3311-3317
31. Heremans Y, Van De Casteele M, in't Veld P, Gradwohl G, Serup P, Madsen O, Pipeleers D, Heimberg H 2002 Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol 159:303-312
32. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H 1998 β-Cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes Dev 12:1763-1768
33. Yoon JC, Xu G, Deeney JT, Yang SN, Rhee J, Puigserver P, Levens AR, Yang R, Zhang CY, Lowell BB, Berggren PO, Newgard CB, Bonner-Weir S, Weir G, Spiegelman BM 2003 Suppression of β cell energy metabolism and insulin release by PGC-1α. Dev Cell 5:73-83
34. Thomas MK, Devon ON, Lee JH, Peter A, Schlosser DA, Tenser MS, Habener JF 2001 Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest 108:319-329
35. Schneider S, Buchert M, Georgiev O, Catimel B, Halford M, Stacker SA, Baechi T, Moelling K, Hovens CM 1999 Mutagenesis and selection of PDZ domains that bind new protein targets. Nat Biotechnol 17:170-175
36. Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH, Crompton A, Chan AC, Anderson JM, Cantley LC 1997 Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275:73-77
37. Harris BZ, Lim WA 2001 Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 114:3219-3231
38. Sato T, Irie S, Kitada S, Reed JC 1995 FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411-415
39. Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP 2004 Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene 23:5632-5642
40. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR 1997 Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-572
41. Baba T, Shimizu T, Suzuki Y, Ogawara M, Isono K, Koseki H, Kurosawa H, Shirasawa T 2005 Estrogen, insulin, and dietary signals cooperatively regulate longevity signals to enhance resistance to oxidative stress in mice. J Biol Chem 280:16417-16426
42. Merimee TJ, Tyson JE 1974 Stabilization of plasma glucose during fasting; Normal variations in two separate studies. N Engl J Med 291:1275-1278
43. Amiel SA, Maran A, Powrie JK, Umpleby AM, Macdonald IA 1993 Gender differences in counterregulation to hypoglycaemia. Diabetologia 36:460-464
44. Davis SN, Galassetti P, Wasserman DH, Tate D 2000 Effects of gender on neuroendocrine and metabolic counterregulatory responses to exercise in normal man. J Clin Endocrinol Metab 85:224-230
45. Nelson WJ, Nusse R 2004 Convergence of Wnt, β-catenin, and cadherin pathways. Science 303:1483-1487
46. Watanabe TK, Saito A, Suzuki M, Fujiwara T, Takahashi E, Slaughter CA, DeMartino GN, Hendil KB, Chung CH, Tanahashi N, Tanaka K 1998 cDNA cloning and characterization of a human proteasomal modulator subunit, p27. Genomics 50:241-250
47. DeMartino GN, Proske RJ, Moomaw CR, Strong AA, Song X, Hisamatsu H, Tanaka K, Slaughter CA 1996 Identification, purification, and characterization of a PA700-dependent activator of the proteasome. J Biol Chem 271:3112-3118
48. Ohana B, Moore PA, Ruben SM, Southgate CD, Green MR, Rosen CA 1993 The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc Natl Acad Sci USA 90:138-142
49. Gonzalez F, Delahodde A, Kodadek T, Johnston SA 2002 Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296:548-550
50. Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP 2001 Regulation of transcriptional activation domain function by ubiquitin. Science 293:1651-1653
51. Ottosen S, Herrera FJ, Triezenberg SJ 2002 Proteasome parts at gene promoters. Science 296:479-481
52. Conaway RC, Brower CS, Conaway JW 2002 Emerging roles of ubiquitin in transcription regulation. Science 296:1254-1258
53. Grossman SR, Deato ME, Brignone C, Chan HM, King AL, Tagami H, Nakatani Y, Livingston DM 2003 Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300:342-344
54. Giles RM, Peters DJM, Breuning MH 1998 Conjunction dysfunction; CBP/p300 in human disease. Trends Genet 14:178-182
55. Yamauchi T, Oike Y, Kamon J, Waki H, Komeda K, Tsuchida A, Date Y, Li MX, Miki H, Akanuma Y, Nagai R, Kimura S, Saheki T, Nakazato M, Naitoh T, Yamamura K, Kadowaki T 2002 Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice. Nat Genet 30:221-226
56. Picard F, Gehin M, Annicotte JS, Rocchi S, Champy MF, O'Malley BW, Chambon P, Auwerx J 2002 SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111:931-941
57. Puigserver P, Spiegelman BM 2003 Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocr Rev 24:78-90
58. Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, Kimura S, Kadowaki T 2002 A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45:740-743
59. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS 1999 Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23:323-328
60. Eeckhoute J, Formstecher P, Laine B 2001 Maturityonset diabetes of the young type 1 (MODY1)-associated mutations R154X and E2767Q in hepatocyte nuclear factor 4α (HNF4α) gene impair recruitment of p300, a key transcriptional coactivator. Mol Endocrinol 15:1200-1210
61. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander ES, Groop LC 1996 Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 14:90-94
62. Shaw JT, Lovelock PK, Kesting JB, Cardinal J, Duffy D, Wainwright B, Cameron DP 1998 Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes 47:173-1796
63. Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL, Vaske D, Briley D, Briley L, Kopf J, McMillen P, Nguyen Q, Reisman M, Lai EH, Joslyn G, Shepherd NS, Bell C, Wagner MJ, Burns DK 2000 Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 66:1871-1881
64. Lindgren CM, Mahtani MM, Widen E, McCarthy MI, Daly MJ, Kirby A, Reeve MP, Kruglyak L, Parker A, Meyer J, Almgren P, Lehto M, Kanninen T, Tuomi T, Groop LC, Lander ES 2002 Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet 70:509-516
65. Frayling TM, Lindgren CM, Chevre JC, Menzel S, Wishart M, Benmezroua Y, Brown A, Evans JC, Rao PS, Dina C, Lecoeur C, Kanninen T, Almgren P, Bulman MP, Wang Y, Mills J, Wright-Pascoe R, Mahtani MM, Prisco F, Costa A, Cognet I, Hansen T, Pedersen O, Ellard S, Tuomi T, Groop LC, Froguel P, Hattersley AT, Vaxillaire M 2003 A genome-wide scan in families with maturity-onset diabetes of the young. Diabetes 52:872-881
66. Wiltshire S, Frayling TM, Groves CJ, Levy JC, Hitman GA, Sampson M, Walker M, Menzel S, Hattersley AT, Cardon LR, McCarthy MI 2004 Evidence from a large U.K. family collection that genes influencing age of onset of Type 2 diabetes map to chromosome 12p and to the MODY3/NIDDM2 locus on 12q24. Diabetes 53:855-860
67. Shang Y, Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468
68. Hogan B, Beddington R, Costantini F, Lacy E 1994 Manipulating the mouse embryo: a laboratory manual. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press;
69. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K 1994 Current protocols in molecular biology. New York: John Wiley and Sons
70. Andreassen OA, Dedeoglu A, Stanojevic V, Hughes DB, Browne SE, Leech CA, Ferrante RJ, Habener JF, Beal MF, Thomas MK 2002 Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol Dis 11:410-424
71. Thomas MK, Rastalsky N, Lee JH, Habener JF 2000 Hedgehog signaling regulation of insulin production by pancreatic β-cells. Diabetes 49:2039-2047
72. Harlow E, Lane D 1999 Using antibodies: a laboratory manual. Plainview, NY: Cold Spring Harbor Laboratory Press
73. Boushey RP, Abadir A, Flamez D, Baggio LL, Li Y, Berger V, Marshall BA, Finegood D, Wang TC, Schuit F, Drucker DJ 2003 Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene. Gastroenterology 125:1164-1174
74. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H 1995 Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769
75. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H 1996 Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93:10933-10938